The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Thrombotic Microangiopathy and the Kidney
Open accessAbstract
Thrombotic microangiopathy can manifest in a diverse range of diseases and is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and organ injury, including AKI. It can be associated with significant morbidity and mortality, but a systematic approach to investigation and prompt initiation of supportive management and, in some cases, effective specific treatment can result in good outcomes. This review considers the classification, pathology, epidemiology, characteristics, and pathogenesis of the thrombotic microangiopathies, and outlines a pragmatic approach to diagnosis and management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Complement: a key system for immune surveillance and homeostasis
Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010) · Nature Immunology · doi:10.1038/ni.1923 · Cited by 3,654
Steegers, E. A., von Dadelszen, P., Duvekot, J. J., & Pijnenborg, R. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60279-6 · Cited by 2,850
Padmanabhan, A., Connelly‐Smith, L., Aqui, N., Balogun, R. A., Klingel, R., Meyer, E., Pham, H. P., Schneiderman, J., Witt, V., Wu, Y., et al. (2019) · Journal of Clinical Apheresis · doi:10.1002/jca.21705 · Cited by 2,230
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
Tarr, P. I., Gordon, C. A., & Chandler, W. L. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71144-2 · Cited by 1,774
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome
Legendre, C. M., Licht, C., Muus, P., Greenbaum, L. A., Babu, S., Bedrosian, C., Bingham, C., Cohen, D. J., Delmas, Y., Douglas, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208981 · Cited by 1,586
VEGF Inhibition and Renal Thrombotic Microangiopathy
Eremina, V., Jefferson, J. A., Kowalewska, J., Hochster, H., Haas, M., Weisstuch, J., Richardson, C., Kopp, J. B., Kabir, M. G., Backx, P. H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707330 · Cited by 1,504
Syndromes of Thrombotic Microangiopathy
George, J. N., & Nester, C. M. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1312353 · Cited by 1,279
Moake, J. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020528 · Cited by 1,221
Noris, M., Caprioli, J., Bresin, E., Mossali, C., Pianetti, G., Gamba, S., Daina, E., Fenili, C., Castelletti, F., Sorosina, A., et al. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02210310 · Cited by 1,042
Schwartz, J., Padmanabhan, A., Aqui, N., Balogun, R. A., Connelly‐Smith, L., Delaney, M., Dunbar, N. M., Witt, V., Wu, Y., & Shaz, B. H. (2016) · Journal of Clinical Apheresis · doi:10.1002/jca.21470 · Cited by 793
Caprioli, J., Noris, M., Brioschi, S., Pianetti, G., Castelletti, F., Bettinaglio, P., Mele, C., Bresin, E., Cassis, L., Gamba, S., et al. (2006) · Blood · doi:10.1182/blood-2005-10-007252 · Cited by 732
Self-citationFremeaux-Bacchi, V., Fakhouri, F., Garnier, A., Bienaimé, F., Dragon-Durey, M.-A., Ngo, S., Moulin, B., Servais, A., Provot, F., Rostaing, L., et al. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04760512 · Cited by 714
Goodship, T. H. J., Cook, H. T., Fakhouri, F., Fervenza, F. C., Frémeaux-Bacchi, V., Kavanagh, D., Nester, C. M., Noris, M., Pickering, M. C., Rodríguez de Córdoba, S., et al. (2017) · Kidney International · doi:10.1016/j.kint.2016.10.005 · Cited by 701
Self-citationInternational, F. H., Loirat, C., Fakhouri, F., Ariceta, G., Besbas, N., Bitzan, M., Bjerre, A., Coppo, R., Emma, F., Johnson, S., et al. (2016) · Pediatric Nephrology · doi:10.1007/s00467-015-3076-8 · Cited by 596
Fakhouri, F., Zuber, J., Frémeaux-Bacchi, V., & Loirat, C. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30062-4 · Cited by 571
Thrombomodulin Mutations in Atypical Hemolytic–Uremic Syndrome
Delvaeye, M., Noris, M., De Vriese, A., Esmon, C. T., Esmon, N. L., Ferrell, G., Del-Favero, J., Plaisance, S., Claes, B., Lambrechts, D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810739 · Cited by 554
Scully, M., Cataland, S., Coppo, P., de la Rubia, J., Friedman, K. D., Kremer Hovinga, J., Lämmle, B., Matsumoto, M., Pavenski, K., Sadler, E., et al. (2017) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13571 · Cited by 506
Anti–Factor H Autoantibodies Associated with Atypical Hemolytic Uremic Syndrome
Dragon-Durey, M.-A. G. A., Loirat, C., Cloarec, S., Macher, M.-A., Blouin, J., Nivet, H., Weiss, L., Fridman, W. H., & Frémeaux-Bacchi, V. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004050380 · Cited by 502
Genetic studies into inherited and sporadic hemolytic uremic syndrome
Warwicker, P., Goodship, T. H. J., Donne, R. L., Pirson, Y., Nicholls, A., Ward, R. M., Turnpenny, P., & Goodship, J. A. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00824.x · Cited by 497
Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies
on behalf of the French Study Group for aHUS/C3G, Zuber, J., Fakhouri, F., Roumenina, L. T., Loirat, C., & Frémeaux-Bacchi, V. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.214 · Cited by 496
Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome
Lemaire, M., Frémeaux-Bacchi, V., Schaefer, F., Choi, M., Tang, W. H., Le Quintrec, M., Fakhouri, F., Taque, S., Nobili, F., Martinez, F., et al. (2013) · Nature Genetics · doi:10.1038/ng.2590 · Cited by 483
临床实践中治疗性单采术应用指南——基于美国血浆置换学会编写委员会的循证策略:第七版
Schwartz, J., Padmanabhan, A., Aqui, N., Balogun, R. A., Connelly‐Smith, L., Delaney, M., Dunbar, N. M., Witt, V., Wu, Y., & Shaz, B. H. (2016) · Journal of Clinical Apheresis · doi:10.1002/jca.21470_c · Cited by 473
Eculizumab in Severe Shiga-Toxin–Associated HUS
Lapeyraque, A.-L., Malina, M., Fremeaux-Bacchi, V., Boppel, T., Kirschfink, M., Oualha, M., Proulx, F., Clermont, M.-J., Le Deist, F., Niaudet, P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmc1100859 · Cited by 423
Licht, C., Greenbaum, L. A., Muus, P., Babu, S., Bedrosian, C. L., Cohen, D. J., Delmas, Y., Douglas, K., Furman, R. R., Gaber, O. A., et al. (2015) · Kidney International · doi:10.1038/ki.2014.423 · Cited by 420
STEC-HUS, atypical HUS and TTP are all diseases of complement activation
Noris, M., Mescia, F., & Remuzzi, G. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.195 · Cited by 383
Drug-induced thrombotic microangiopathy: a systematic review of published reports
Al-Nouri, Z. L., Reese, J. A., Terrell, D. R., Vesely, S. K., & George, J. N. (2015) · Blood · doi:10.1182/blood-2014-11-611335 · Cited by 367
Moore, I., Strain, L., Pappworth, I., Kavanagh, D., Barlow, P. N., Herbert, A. P., Schmidt, C. Q., Staniforth, S. J., Holmes, L. V., Ward, R., et al. (2010) · Blood · doi:10.1182/blood-2009-05-221549 · Cited by 357
Self-citationAtypical Hemolytic Uremic Syndrome
Kavanagh, D., Goodship, T. H., & Richards, A. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.08.003 · Cited by 348
Self-citationRodríguez-Pintó, I., Moitinho, M., Santacreu, I., Shoenfeld, Y., Erkan, D., Espinosa, G., & Cervera, R. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.09.010 · Cited by 319
Menne, J., Nitschke, M., Stingele, R., Abu-Tair, M., Beneke, J., Bramstedt, J., Bremer, J. P., Brunkhorst, R., Busch, V., Dengler, R., et al. (2012) · BMJ · doi:10.1136/bmj.e4565 · Cited by 309
Maga, T. K., Nishimura, C. J., Weaver, A. E., Frees, K. L., & Smith, R. J. H. (2010) · Human Mutation · doi:10.1002/humu.21256 · Cited by 308
Fakhouri, F., Hourmant, M., Campistol, J. M., Cataland, S. R., Espinosa, M., Gaber, A. O., Menne, J., Minetti, E. E., Provôt, F., Rondeau, E., et al. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.12.034 · Cited by 305
Atypical aHUS: State of the art
Nester, C. M., Barbour, T., de Cordoba, S. R., Dragon-Durey, M. A., Fremeaux-Bacchi, V., Goodship, T. H. J., Kavanagh, D., Noris, M., Pickering, M., Sanchez-Corral, P., et al. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.03.246 · Cited by 299
Self-citationScully, M., Thomas, M., Underwood, M., Watson, H., Langley, K., Camilleri, R. S., Clark, A., Creagh, D., Rayment, R., Mcdonald, V., et al. (2014) · Blood · doi:10.1182/blood-2014-02-553131 · Cited by 296
Greenbaum, L. A., Fila, M., Ardissino, G., Al-Akash, S. I., Evans, J., Henning, P., Lieberman, K. V., Maringhini, S., Pape, L., Rees, L., et al. (2016) · Kidney International · doi:10.1016/j.kint.2015.11.026 · Cited by 296
Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria
Kelly, R. J., Höchsmann, B., Szer, J., Kulasekararaj, A., de Guibert, S., Röth, A., Weitz, I. C., Armstrong, E., Risitano, A. M., Patriquin, C. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1502950 · Cited by 286
Salmon, J. E., Heuser, C., Triebwasser, M., Liszewski, M. K., Kavanagh, D., Roumenina, L., Branch, D. W., Goodship, T., Fremeaux-Bacchi, V., & Atkinson, J. P. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001013 · Cited by 285
Self-citationStructural basis for sialic acid–mediated self-recognition by complement factor H
Blaum, B. S., Hannan, J. P., Herbert, A. P., Kavanagh, D., Uhrín, D., & Stehle, T. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1696 · Cited by 278
Self-citationLe Quintrec, M., Zuber, J., Moulin, B., Kamar, N., Jablonski, M., Lionet, A., Chatelet, V., Mousson, C., Mourad, G., Bridoux, F., et al. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12077 · Cited by 268
Jodele, S., Licht, C., Goebel, J., Dixon, B. P., Zhang, K., Sivakumaran, T. A., Davies, S. M., Pluthero, F. G., Lu, L., & Laskin, B. L. (2013) · Blood · doi:10.1182/blood-2013-05-501445 · Cited by 253
Bu, F., Maga, T., Meyer, N. C., Wang, K., Thomas, C. P., Nester, C. M., & Smith, R. J. H. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013050453 · Cited by 242
Kielstein, J. T., Beutel, G., Fleig, S., Steinhoff, J., Meyer, T. N., Hafer, C., Kuhlmann, U., Bramstedt, J., Panzer, U., Vischedyk, M., et al. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs394 · Cited by 239
Thrombotic microangiopathy after renal transplantation in the United States
Reynolds, J. C., Agodoa, L. Y., Yuan, C. M., & Abbott, K. C. (2003) · American Journal of Kidney Diseases · doi:10.1016/j.ajkd.2003.07.008 · Cited by 219
Hemolytic Uremic Syndrome in Pregnancy and Postpartum
Bruel, A., Kavanagh, D., Noris, M., Delmas, Y., Wong, E. K. S., Bresin, E., Provôt, F., Brocklebank, V., Mele, C., Remuzzi, G., et al. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00280117 · Cited by 216
Self-citationComplement Mutation-Associated De Novo Thrombotic Microangiopathy Following Kidney Transplantation
Le Quintrec, M., Lionet, A., Kamar, N., Karras, A., Barbier, S., Buchler, M., Fakhouri, F., Provost, F., Fridman, W. H., Thervet, E., et al. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02297.x · Cited by 203
Childhood Hemolytic Uremic Syndrome, United Kingdom and Ireland
Lynn, R. M., O'Brien, S. J., Taylor, C. M., Adak, G. K., Chart, H., Cheasty, T., Coia, J. E., Gillespie, I. A., Locking, M. E., Reilly, W. J., et al. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1104.040833 · Cited by 199
Fakhouri, F., Fila, M., Provôt, F., Delmas, Y., Barbet, C., Châtelet, V., Rafat, C., Cailliez, M., Hogan, J., Servais, A., et al. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06440616 · Cited by 194
The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy
Jodele, S., Zhang, K., Zou, F., Laskin, B., Dandoy, C. E., Myers, K. C., Lane, A., Meller, J., Medvedovic, M., Chen, J., et al. (2016) · Blood · doi:10.1182/blood-2015-08-663435 · Cited by 190
Infections associated with the use of eculizumab: recommendations for prevention and prophylaxis
Benamu, E., & Montoya, J. G. (2016) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000279 · Cited by 167
Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease
Obrig, T. G. (2010) · Toxins · doi:10.3390/toxins2122769 · Cited by 159
Fakhouri, F., Gourraud‐Vercel, C., & Frémeaux‐Bacchi, V. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.13121211 · Cited by 158
Pathology after Eculizumab in Dense Deposit Disease and C3 GN
Herlitz, L., Bomback, A. S., Markowitz, G. S., Stokes, M. B., Smith, R. N., Colvin, R. B., Appel, G. B., & D’Agati, V. D. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011121186 · Cited by 155
A Clinicopathologic Study of Thrombotic Microangiopathy in IgA Nephropathy
Karoui, K. E., Hill, G. S., Karras, A., Jacquot, C., Moulonguet, L., KOURILSKY, O., Frémeaux‐Bacchi, V., Delahousse, M., Huyen, J. D. V., Loupy, A., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111130 · Cited by 153
DGKE Variants Cause a Glomerular Microangiopathy That Mimics Membranoproliferative GN
Özaltın, F., Li, B., Rauhauser, A. A., An, S.-W., Söylemezoğlu, O., Gönül, İ. I., Taşkıran, E. Z., Ibsirlioglu, T., Korkmaz, E., Bilginer, Y., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012090903 · Cited by 153
Loos, S., Ahlenstiel, T., Kranz, B., Staude, H., Pape, L., Hartel, C., Vester, U., Buchtala, L., Benz, K., Höppe, B., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis531 · Cited by 150
Timmermans, S. A. M. E. G., Hamid, M. A. A., Vanderlocht, J., Damoiseaux, J. G. M. C., Reutelingsperger, C. P. M., van Paassen, P., de Heer, F., Krekels, M. M. E., Stifft, F., Verseput, G. H., et al. (2017) · Kidney International · doi:10.1016/j.kint.2016.12.009 · Cited by 147
Atypical haemolytic uraemic syndrome
Kavanagh, D., Goodship, T. H. J., & Richards, A. (2006) · British Medical Bulletin · doi:10.1093/bmb/ldl004 · Cited by 144
Self-citationMicroangiopathic Hemolysis and Renal Failure in Malignant Hypertension
van den Born, B. H., Honnebier, U. P. F., Koopmans, R. P., & van Montfrans, G. A. (2005) · Hypertension · doi:10.1161/01.hyp.0000151620.17905.ee · Cited by 144
Drug-Induced Thrombotic Microangiopathy: Incidence, Prevention and Management
Pisoni, R., Ruggenenti, P. L., & Remuzzi, G. (2001) · Drug Safety · doi:10.2165/00002018-200124070-00002 · Cited by 140
Thrombotic Microangiopathy, Cancer, and Cancer Drugs
Izzedine, H., & Perazella, M. A. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.02.340 · Cited by 138
Feinberg, J., Hurwitz, S., Cooper, D., Sattler, F. R., MacGregor, R. R., Powderly, W. G., Holland, G. N., Griffiths, P. D., Pollard, R. B., Youle, M. S., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/513804 · Cited by 132
Brandt, J. R., Fouser, L. S., Watkins, S. L., et al. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70002-8 · Cited by 132
Michael, M., Elliott, E. J., Craig, J. C., Ridley, G. F., & Hodson, E. M. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.07.038 · Cited by 123
Meningococcal Sepsis Complicating Eculizumab Treatment Despite Prior Vaccination
Struijk, G. H., Bouts, A. H. M., Rijkers, G. T., Kuin, E. A. C., ten Berge, I. J. M., & Bemelman, F. J. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12032 · Cited by 119
Kavanagh, D., McGlasson, S. L., Jury, A., Williams, J., Scolding, N. J., Bellamy, C. O. C., Günther, C., Ritchie, D. L., Gale, D. P., Kanwar, Y. S., et al. (2016) · Blood · doi:10.1182/blood-2016-05-715987 · Cited by 117
Self-citationSyndromes of thrombotic microangiopathy associated with pregnancy
George, J. N., Nester, C., & McIntosh, J. J. (2015) · Hematology · doi:10.1182/asheducation-2015.1.644 · Cited by 114
Blanc, C., Roumenina, L. T., Ashraf, Y., Hyvärinen, S., Sethi, S. K., Ranchin, B., Niaudet, P., Loirat, C., Gulati, A., Bagga, A., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200679 · Cited by 102
Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity
Beck, B. B., van Spronsen, F. J., Diepstra, A., et al. (2016) · Pediatric Nephrology · doi:10.1007/s00467-016-3399-0 · Cited by 99
Cancer Awareness in Atypical Thrombotic Microangiopathies
Obéric, L., Buffet, M., Schwarzinger, M., Veyradier, A., Clabault, K., Malot, S., SCHLEINITZ, N., Valla, D. C., Galicier, L., Bengrine-Lefèvre, L., et al. (2009) · The Oncologist · doi:10.1634/theoncologist.2009-0067 · Cited by 97
Kerr, H., & Richards, A. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.07.028 · Cited by 95
Sheerin, N., Kavanagh, D., Goodship, T. H. J., et al. (2015) · QJM · doi:10.1093/qjmed/hcv082 · Cited by 95
Self-citationThe role of complement in C3 glomerulopathy
Zipfel, P. F., Skerka, C., Chen, Q., Wiech, T., Goodship, T. H. J., Johnson, S. A., Frémeaux‐Bacchi, V., Nester, C., de Córdoba, S. R., Noris, M., et al. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.03.012 · Cited by 93
Atypical haemolytic uraemic syndrome and pregnancy: outcome with ongoing eculizumab
Servais, A., Devillard, N., Frémeaux‐Bacchi, V., Hummel, A., Salomon, L. J., Contin‐Bordes, C., Gomer, H., Legendre, C. M., & Delmas, Y. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw314 · Cited by 88
Loss of DGKε induces endothelial cell activation and death independently of complement activation
Bruneau, S., Néel, M., Roumenina, L. T., Frimat, M., Laurent, L., Frémeaux‐Bacchi, V., & Fakhouri, F. (2014) · Blood · doi:10.1182/blood-2014-06-579953 · Cited by 86
Wong, E. K. S., & Kavanagh, D. (2014) · Translational research · doi:10.1016/j.trsl.2014.10.010 · Cited by 82
Self-citationThurman, J. M., & Nester, C. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01710216 · Cited by 81
Streptococcus pneumoniae-associated Hemolytic Uremic Syndrome Among Children in North America
Banerjee, R., Hersh, A. L., Newland, J. G., Beekmann, S. E., Polgreen, P. M., Bender, J. M., Shaw, J., Copelovitch, L. A., Kaplan, B. S., & Shah, S. S. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3182191c58 · Cited by 76
Manenti, L., Gnappi, E., Vaglio, A., Allegri, L., Noris, M., Bresin, E., Pilato, F. P., Valoti, E., Pasquali, S., & Buzio, C. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft220 · Cited by 73
Complement Mutations in Diacylglycerol Kinase-ε–Associated Atypical Hemolytic Uremic Syndrome
Chinchilla, D. S., Pinto, S., Höppe, B., Adragna, M. S., Lopez, L., Roldán, M. L. J., Peña, A., López‐Trascasa, M., Sánchez‐Corral, P., & de Córdoba, S. R. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01640214 · Cited by 72
Long-term renal outcome in patients with malignant hypertension: a retrospective cohort study
Amraoui, F., Bos, S., Vogt, L., & van den Born, B. H. (2012) · BMC Nephrology · doi:10.1186/1471-2369-13-71 · Cited by 71
Brocklebank, V., Johnson, S. A., Sheerin, T. P., et al. (2017) · Kidney International · doi:10.1016/j.kint.2017.04.028 · Cited by 71
Self-citationPregnancy-related thrombotic microangiopathies: Clues from complement biology
Fakhouri, F. (2016) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2016.04.009 · Cited by 68
Brocklebank, V., & Kavanagh, D. (2017) · Clinical Kidney Journal · doi:10.1093/ckj/sfx081 · Cited by 66
Self-citationEvaluation of Clinical Outcomes and Renal Vascular Pathology among Patients with Lupus
Barber, C. E. H., Herzenberg, A. M., Aghdassi, E., Su, J., Lou, W. Y. W., Gan, Q., Yip, J., Nasr, S. H., Thomas, D. B., Scholey, J. W., et al. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02870311 · Cited by 64
Factor I Autoantibodies in Patients with Atypical Hemolytic Uremic Syndrome
Kavanagh, D., Pappworth, I. Y., Anderson, H. E., Hayes, C. M., Moore, I., Hunze, E.-M., Bennaceur, K., Roversi, P., Lea, S. M., Strain, L., et al. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05750611 · Cited by 61
Self-citationMele, C., Lemaire, M. J., Iatropoulos, P., Piras, R., Bresin, E., Bettoni, S., Bick, D. P., Helbling, D. C., Veith, R. L., Valoti, E., et al. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08520814 · Cited by 59
Brigotti, M., Caprioli, A., Tozzi, A. E., Tazzari, P. L., Ricci, F., Conte, R., Carnicelli, D., Procaccino, M. A., Minelli, F., Ferretti, A. V. S., et al. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.2.313-317.2006 · Cited by 58
Transplantation in Atypical Hemolytic Uremic Syndrome
Kavanagh, D., Richards, A., Goodship, T. H. J., & Jalanko, H. (2010) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0030-1262887 · Cited by 54
Self-citationThrombotic Microangiopathy in Inverted Formin 2–Mediated Renal Disease
Challis, R. C., Ring, T., Xu, Y., Wong, E. K. S., Floßmann, O., Roberts, I. S. D., Ahmed, S., Wetherall, M., Salkus, G., Brocklebank, V., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015101189 · Cited by 53
Self-citationBenhamou, Y., Paintaud, G., Azoulay, É., Poullin, P., Galicier, L., Desvignes, C., Baudel, J.-L., Peltier, J., Mira, J. P., Pène, F., et al. (2016) · American Journal of Hematology · doi:10.1002/ajh.24559 · Cited by 51
Eculizumab hepatotoxicity in pediatric aHUS
Hayes, W. N., Tschumi, S., Ling, S. C., Feber, J., Kirschfink, M., & Licht, C. P. B. (2014) · Pediatric Nephrology · doi:10.1007/s00467-014-2990-5 · Cited by 49
The genetics of the alternative pathway of complement in the pathogenesis of HELLP syndrome
Crovetto, F., Borsa, N. G., Acaia, B., Nishimura, C. J., Frees, K. L., Smith, R. J., Peyvandi, F., Palla, R., Cugno, M., Tedeschi, S., et al. (2012) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2012.694923 · Cited by 41
Phillips, E. H., Westwood, J., Brocklebank, V., Wong, E. K. S., Tellez, J. O., Marchbank, K. J., McGuckin, S., Gale, D. P., Connolly, J. O., Goodship, T. H. J., et al. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13189 · Cited by 38
Self-citationSevere hypertension with renal thrombotic microangiopathy: what happened to the usual suspect?
Laecke, S. V., & Biesen, W. V. (2017) · Kidney International · doi:10.1016/j.kint.2017.02.025 · Cited by 34
Diagnosis and Treatment of the Hemolytic Uremic Syndrome Disease Spectrum in Developing Regions
Hofer, J., Giner, T., & Safouh, H. (2014) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0034-1376154 · Cited by 28
Is complement a culprit in infection-induced forms of haemolytic uraemic syndrome?
Johnson, S. A., & Waters, A. M. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.07.022 · Cited by 27
Research works printed but not linked: 34
- Barrera-Vargas, 2016, Renal thrombotic microangiopathy in proliferative lupus nephritis: Risk factors and clinical outcomes: A Case-Control study, J Clin Rheumatol, 22, 235, 10.1097/RHU.0000000000000425 · doi:10.1097/rhu.0000000000000425
- Saland, 2014, Liver-kidney transplantation to cure atypical HUS: Still an option post-eculizumab?, Pediatr Nephrol, 29, 329, 10.1007/s00467-013-2722-2 · doi:10.1007/s00467-013-2722-2
- Brocklebank, Factor H: Autoantibody associated atypical haemolytic uraemic syndrome in children in the United Kingdom and Ireland [published online ahead of print July 24, 2017], Kidney Int
- Nishijima, 2013, Drug-induced thrombotic thrombocytopenic purpura successfully treated with recombinant human soluble thrombomodulin, Intern Med, 52, 1111, 10.2169/internalmedicine.52.9180 · doi:10.2169/internalmedicine.52.9180
- Alashkar, 2017, Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab, Ann Hematol, 96, 589, 10.1007/s00277-017-2924-y · doi:10.1007/s00277-017-2924-y
- Cullinan, 2015, Case report: Benefits and challenges of long-term eculizumab in atypical hemolytic uremic syndrome, Pediatrics, 135, e1506, 10.1542/peds.2014-3503 · DOI
- George, 2003, The association of pregnancy with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, Curr Opin Hematol, 10, 339, 10.1097/00062752-200309000-00003 · doi:10.1097/00062752-200309000-00003
- Scully, 2011, A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura, Blood, 118, 1746, 10.1182/blood-2011-03-341131 · doi:10.1182/blood-2011-03-341131
- Clark, 2015, A phase-II sequential case-series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab, Br J Haematol, 170, 208, 10.1111/bjh.13408 · doi:10.1111/bjh.13408
- Westland, 2014, Phenotypic expansion of DGKE-associated diseases, J Am Soc Nephrol, 25, 1408, 10.1681/ASN.2013080886 · doi:10.1681/asn.2013080886
- Hughes, 2002, Molecular basis for high renal cell sensitivity to the cytotoxic effects of shigatoxin-1: Upregulation of globotriaosylceramide expression, J Am Soc Nephrol, 13, 2239, 10.1097/01.ASN.0000027873.85792.52 · doi:10.1097/01.asn.0000027873.85792.52
- Spinale, 2013, Long-term outcomes of Shiga toxin hemolytic uremic syndrome, Pediatr Nephrol, 28, 2097, 10.1007/s00467-012-2383-6 · doi:10.1007/s00467-012-2383-6
- Spinale, 2013, Update on Streptococcus pneumoniae associated hemolytic uremic syndrome, Curr Opin Pediatr, 25, 203, 10.1097/MOP.0b013e32835d7f2c · doi:10.1097/mop.0b013e32835d7f2c
- Alpers, 2003, Light at the end of the TUNEL: HIV-associated thrombotic microangiopathy, Kidney Int, 63, 385, 10.1046/j.1523-1755.2003.00743.x · doi:10.1046/j.1523-1755.2003.00743.x
- Peraldi, 1999, Acute renal failure in the course of HIV infection: A single-institution retrospective study of ninety-two patients and sixty renal biopsies, Nephrol Dial Transplant, 14, 1578, 10.1093/ndt/14.6.1578 · doi:10.1093/ndt/14.6.1578
- Becker, 2004, HIV-associated thrombotic microangiopathy in the era of highly active antiretroviral therapy: An observational study, Clin Infect Dis, 39, S267, 10.1086/422363 · doi:10.1086/422363
- Gottschall, 1991, Quinine-induced immune thrombocytopenia associated with hemolytic uremic syndrome: A new clinical entity, Blood, 77, 306, 10.1182/blood.V77.2.306.306 · doi:10.1182/blood.v77.2.306.306
- Bennett, 2013, Ticlopidine-associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: A report from the Southern Network on Adverse Reactions (SONAR), Br J Haematol, 161, 896, 10.1111/bjh.12303 · doi:10.1111/bjh.12303
- Verbiest, 2014, De novo thrombotic microangiopathy after non-renal solid organ transplantation, Blood Rev, 28, 269, 10.1016/j.blre.2014.09.001 · doi:10.1016/j.blre.2014.09.001
- Ponticelli, 2006, Thrombotic microangiopathy after kidney transplantation, Transpl Int, 19, 789, 10.1111/j.1432-2277.2006.00354.x · doi:10.1111/j.1432-2277.2006.00354.x
- Zuber, 2013, Targeted strategies in the prevention and management of atypical HUS recurrence after kidney transplantation, Transplant Rev (Orlando), 27, 117, 10.1016/j.trre.2013.07.003 · doi:10.1016/j.trre.2013.07.003
- Dhakal, 2017, Is complement blockade an acceptable therapeutic strategy for hematopoietic cell transplant-associated thrombotic microangiopathy?, Bone Marrow Transplant, 52, 352, 10.1038/bmt.2016.253 · doi:10.1038/bmt.2016.253
- Shavit, 2010, Severe renal failure and microangiopathic hemolysis induced by malignant hypertension--case series and review of literature, Clin Nephrol, 73, 147, 10.5414/CNP73147 · doi:10.5414/cnp73147
- George, 2011, Systemic malignancies as a cause of unexpected microangiopathic hemolytic anemia and thrombocytopenia, Oncology (Williston Park), 25, 908
- Lesesne, 1989, Cancer-associated hemolytic-uremic syndrome: Analysis of 85 cases from a national registry, J Clin Oncol, 7, 781, 10.1200/JCO.1989.7.6.781 · doi:10.1200/jco.1989.7.6.781
- Cooper, 2004, Familial mesangio-capillary glomerulonephritis with initial presentation as haemolytic uraemic syndrome, Nephrol Dial Transplant, 19, 230, 10.1093/ndt/gfg470 · doi:10.1093/ndt/gfg470
- Woodworth, 2016, Scleroderma renal crisis and renal involvement in systemic sclerosis, Nat Rev Nephrol, 12, 678, 10.1038/nrneph.2016.124 · doi:10.1038/nrneph.2016.124
- Fakhouri, Haemolytic uraemic syndrome [published online ahead of print February 25, 2017], Lancet
- Waters, 2007, Hemolytic uremic syndrome associated with invasive pneumococcal disease: The United kingdom experience, J Pediatr, 151, 140, 10.1016/j.jpeds.2007.03.055 · doi:10.1016/j.jpeds.2007.03.055
- Cochran, 2004, Pneumococcus-induced T-antigen activation in hemolytic uremic syndrome and anemia, Pediatr Nephrol, 19, 317, 10.1007/s00467-003-1382-z · doi:10.1007/s00467-003-1382-z
- Prestidge, 2009, Ten years of pneumococcal-associated haemolytic uraemic syndrome in New Zealand children, J Paediatr Child Health, 45, 731, 10.1111/j.1440-1754.2009.01603.x · doi:10.1111/j.1440-1754.2009.01603.x
- van den Born, 2007, The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension, Am J Hypertens, 20, 900, 10.1016/j.amjhyper.2007.02.018 · doi:10.1016/j.amjhyper.2007.02.018
- Akimoto, 2011, Clinical features of malignant hypertension with thrombotic microangiopathy, Clin Exp Hypertens, 33, 77, 10.3109/10641963.2010.503303 · DOI
- Ghossein, 2016, Recent developments in the classification, evaluation, pathophysiology, and management of scleroderma renal crisis, Curr Rheumatol Rep, 18, 5, 10.1007/s11926-015-0551-y · doi:10.1007/s11926-015-0551-y
Cited by
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Rovin, B. H., Adler, S. G., Barratt, J., Bridoux, F., Burdge, K. A., Chan, T. M., Cook, H. T., Fervenza, F. C., Gibson, K. L., Glassock, R. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.05.021 · Cited by 2,518
Pre-eclampsia: pathogenesis, novel diagnostics and therapies
Phipps, E. A., Thadhani, R., Benzing, T., & Karumanchi, S. A. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0119-6 · Cited by 1,191
Rapkiewicz, A. V., Mai, X., Carsons, S. E., Pittaluga, S., Kleiner, D. E., Berger, J. S., Thomas, S., Adler, N. M., Charytan, D. M., Gasmi, B., et al. (2020) · eClinicalMedicine · doi:10.1016/j.eclinm.2020.100434 · Cited by 533
KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS
Rovin, B. H., Ayoub, I. M., Chan, T. M., Liu, Z.-H., Mejía-Vilet, J. M., & Floege, J. (2024) · Kidney International · doi:10.1016/j.kint.2023.09.002 · Cited by 517
Chand, D. H., Zaidman, C., Arya, K., Millner, R., Farrar, M. A., Mackie, F. E., Goedeker, N. L., Dharnidharka, V. R., Dandamudi, R., & Reyna, S. P. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2020.11.054 · Cited by 210
Metadata
- Authors
- Brocklebank, V., Wood, K. M., & Kavanagh, D.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2017-10-17
- Volume
- 13
- Issue
- 2
- Pages
- 300-317
- ISSN
- 1555-9041 (ISSN-L)
- 1555-905X
- OpenAlex
- W2765086424
- Cited by
- 373
- References
- 96
- FWCI
- 8.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.